Stephan Johannes Schüler (born 1967), specialist in neurology from Germany, from where he has his dr. med., senior consultant. The author has completed the ICMJE form and reports no conflicts of ...
Pål Kristensen (born 1963) specialist in psychology and dr. philos. He has contributed to the idea, literature review, interpretation of data and revision of the manuscript. The author has completed ...
Tor Halvor Bjørnstad-Tuveng, specialist in general practice, specialty registrar in community medicine, district medical officer and general practitioner. He is the medical officer for the COVID-19 ...
Oliwia Witczak (born 1971), nutritionist and associate professor of biomedical sciences at the Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences. Trine B. Haugen ...
Synovial fluid is examined as a matter of routine in evaluations of swollen joints. Microscopic examination is used to assess cellularity and the cell types present and to determine whether there are ...
Ellen Jørum (born 1954) MD, PhD, specialist in neurophysiology and neurology, senior consultant and professor. The author has completed the ICMJE form and declares no conflicts of interest. French ...
New vaccines against COVID-19 are being rolled out globally. AstraZeneca's vaccine ChAdOx1 nCoV-19 was not known to cause vaccine-induced immune thrombotic thrombocytopenia (VITT) at the time of this ...
He has contributed to the concept, design, drafting and revision of the manuscript. Mats Døving, specialty registrar in maxillofacial surgery. He is also a dental student in the Faculty of Dentistry, ...
Han har bidratt med utforming av spørreskjemaet, analyse og fortolkning av data, manusrevisjon og har godkjent innsendte manusversjon. Morten Magelssen er ph.d. i medisinsk etikk og forsker. Forfatter ...
Dagfinn Skaare er ph.d., spesialist i medisinsk mikrobiologi og overlege. Han leder en forskningsgruppe innenfor antibiotikaresistens finansiert av strategiske forskningsmidler fra Helse Sør-Øst.
Én enkeltdose subanestetisk intravenøs racemisk ketamin er vist å være effektivt mot depresjon i flere enn 20 dobbeltblindede, randomiserte, kontrollerte studier (DB-RCT) og flere metaanalyser (8).
Tidsskrift for Den norske legeforening, Postboks 1152 Sentrum, 0107 OSLO Sentralbord: 23 10 90 00 • E-post: [email protected] Sjefredaktør Are Brean • Tidsskriftet er et ...